Axys drug discovery news

AXPH established an Advanced Technologies Division that will include the company's combinatorial chemistry and pharmacogenomics technologies, as well as its Delta protease structure-based drug design technology. The division will include an ongoing combinatorial chemistry collaboration with Pharmacia & Upjohn (Kalamazoo, Mich.). AXPH was created by the merger of Arris Pharmaceutical Corp. (ARRS, South San Francisco, Calif.) and Sequana Therapeutics Inc. (SQNA, La Jolla, Calif.). ...